A 100% Brazilian company, founded 53 years ago, Aché is positioned among the three largest pharmaceutical corporations in Brazil, fulfilling the purpose of bringing more life to people wherever they are. By maintaining its focus on innovation and operational excellence, it makes available to the market products with recognized quality, innovative and accessible.
It employs approximately 5,000 employees and has one of the largest demand generation and sales forces in the pharmaceutical sector in Brazil. In order to meet the needs of healthcare professionals and consumers, Aché offers a portfolio of 357 brands in 899 submissions for prescription, generic and OTC (non-prescription) drugs, covering 142 therapeutic classes and 18 medical specialties. Aché's products, developed for registration in highly regulated markets, are present in 29 countries in Latin America, Africa, Asia and Europe, including: Brazil, Saudi Arabia, Algeria, Cape Verde, Qatar, Chile, Colombia, Costa Rica, El Salvador, United Arab Emirates, Ecuador, Georgia, Guatemala, Honduras, Japan, Kuwait, Libya, Mexico, Mozambique, Nicaragua, Oman, Panama, Paraguay , Peru, Dominican Republic, Ukraine, Uruguay, Venezuela, Vietnam.
It has five industrial plants: in São Paulo, capital; in Guarulhos, state of São Paulo; in Londrina, Paraná - Nortis company; in Anápolis, state of Goiás - Melcon company, our most recent acquisition, and in Cabo de Santo Agostinho, Pernambuco. In addition, the company owns 25% of Bionovis as a result of a joint venture with three other Brazilian pharmaceutical companies.